COMMUNIQUÉS West-GlobeNewswire

-
G1 Therapeutics Announces Appointment of New Members to the Board of Directors
08/06/2018 -
Fennec Announces Results of Annual Meeting
08/06/2018 -
Amicus Therapeutics Appoints President and COO Bradley L. Campbell to Board of Directors
08/06/2018 -
XORTX Announces Filing of FDA pre-IND Meeting Request Letter
08/06/2018 -
Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
08/06/2018 -
Solon Eiendom ASA : LAST DAY OF SUBSCRIPTION PERIOD IN THE SUBSEQUENT OFFERING
08/06/2018 -
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2017 – April 30, 2018
08/06/2018 -
Shire plc : Rule 2.9 Announcement
08/06/2018 -
Celixir announces US FDA approval of the IND application for cell therapy Heartcel
08/06/2018 -
Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant
08/06/2018 -
IBA SA : IBA Signs Contract to Install Cyclone® 70 System in Arizona, USA
08/06/2018 -
IBA SA : IBA Signe un Contrat pour l'installation d'un Cyclotron 70 MeV en Arizona, États-Unis
08/06/2018 -
Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
07/06/2018 -
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2018 -
EDAP TMS SA : EDAP Announces FDA Clearance for Focal One®
07/06/2018 -
Helix BioPharma Corp. Closes Private Placement
07/06/2018 -
Intercept to Present at Upcoming Conference
07/06/2018 -
Adamas to Present at Two Upcoming Investor Conferences
07/06/2018 -
AIT Therapeutics Announces Change to Fiscal Year End and Financial Results Conference Call and Webcast for the Three Months Ended March 31, 2018
07/06/2018
Pages